Top compounds associated with response to LINC00675


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.00028 1
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC 0.00027 1
mRNA RAF265 CCLE pan-cancer AAC -0.00014 1
mRNA apicidin CTRPv2 pan-cancer AAC -2.1e-05 1
Download CSV